Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05804825 · ClinicalTrials.gov registry record · NA
Testing the Persuasiveness of Pro-inoculation Arguments
A NA study of Vaccine Refusal and Human Papillomavirus Vaccination, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 523
- Enrollment target
- 1
- Study location
NCT05804825 is a NA study of Vaccine Refusal and Human Papillomavirus Vaccination that has completed, run by University of Pennsylvania. The registered enrollment target is 523 participants, below the 1,213-participant average among 5 other Vaccine Refusal trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05804825, a NA study of Vaccine Refusal and Human Papillomavirus Vaccination, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 523 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators will recruit a national sample of parents of 7-10-year-olds to complete an argument strength ranking for either a simple forwarding message or between 3 and 6 randomly selected arguments from an overall set of 50 to 100 messages identified from various online sources. Parents will rate each message they see on measures of perceived argument strength/PME. Parents will also answer sociodemographic questions and then rank the believability of a set of anti-vaccine messages identified in a different study. Study findings will contribute valuable information to understanding the effectiveness of different inoculation messages.
Conditions Studied
Interventions
- BEHAVIORAL Argument inoculation messages
- BEHAVIORAL Simple forewarning message
Study Locations (1)
Pennsylvania
- UPenn - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 523 participants |
| Start Date | 2023-05-04 |
| Est. Completion | 2023-05-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05804825
The ClinicalTrials.gov registry entry for NCT05804825 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 523 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,213-participant average among 5 other Vaccine Refusal trials with a reported enrollment target (57% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Vaccine Refusal appearing as the primary indexed condition, and to 2 interventions - of which Argument inoculation messages is the first listed.
NCT05804825 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05804825 about?
NCT05804825 is a clinical study titled "Testing the Persuasiveness of Pro-inoculation Arguments". The investigators will recruit a national sample of parents of 7-10-year-olds to complete an argument strength ranking for either a simple forwarding message or between 3 and 6 randomly selected arguments from an overall set of 50 to 100 messages identified from various online sources. Parents will ...
What is the current status of trial NCT05804825?
This trial is currently completed. It is a NA study. The enrollment target is 523 participants. The study started on 2023-05-04. Estimated completion is 2023-05-24.
What conditions does trial NCT05804825 study?
This clinical trial studies the following conditions: Vaccine Refusal, Human Papillomavirus Vaccination, Vaccination Hesitancy.
What interventions are being tested in trial NCT05804825?
The interventions under investigation include: Argument inoculation messages (BEHAVIORAL), Simple forewarning message (BEHAVIORAL).
Who is sponsoring clinical trial NCT05804825?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05804825 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaccine Refusal
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Vaccine Acceptance Through EHR Integrated Patient- and Provider-Facing Decision Support
RECRUITING · NA
-
Improving Vaccine Counseling Skills Among Residents Using Educational Modules and Standardized Patient Encounters
COMPLETED · NA
-
Use of Construal Level Theory to Inform Messaging to Increase Vaccination Against COVID-19
COMPLETED · NA
-
Vaccine Confidence Study Among Historically Marginalized Racial and Ethnic Groups
RECRUITING
-
Vaccine Hesitancy: A Survey of Pediatric Clinicians
COMPLETED
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.